Inovio Pharmaceuticals Market Cap

Inovio Pharmaceuticals has a market cap or net worth of $64.53 million as of April 15, 2025. Its market cap has decreased by -78.95% in one year.

Market Cap

64.53M

Enterprise Value

-17.53M

1-Year Change

-78.95%

Ranking

#4246

Market Cap Chart

Since March 31, 1999, Inovio Pharmaceuticals's market cap has decreased from $71.80M to $64.53M, a decrease of -10.12%. That is a compound annual growth rate of -0.41%.

Market Cap History

Date	Market Cap	% Change
Apr 15, 2025	64.50M	34.94%
Dec 31, 2024	47.80M	-65.66%
Dec 29, 2023	139.20M	-64.23%
Dec 30, 2022	389.20M	-62.93%
Dec 31, 2021	1.05B	-29.98%
Dec 31, 2020	1.50B	354.33%
Dec 31, 2019	330.00M	-13.48%
Dec 31, 2018	381.40M	2.28%
Dec 29, 2017	372.90M	-27.45%
Dec 30, 2016	514.00M	5.96%
Dec 31, 2015	485.10M	-12.78%
Dec 31, 2014	556.20M	-7.96%
Dec 31, 2013	604.30M	768.25%
Dec 31, 2012	69.60M	27.71%
Dec 30, 2011	54.50M	-54.51%
Dec 31, 2010	119.80M	2.92%
Dec 31, 2009	116.40M	408.30%
Dec 31, 2008	22.90M	-43.18%
Dec 31, 2007	40.30M	-65.53%
Dec 29, 2006	116.90M	163.88%
Dec 30, 2005	44.30M	-38.64%
Dec 31, 2004	72.20M	-1.77%
Dec 31, 2003	73.50M	440.44%
Dec 31, 2002	13.60M	-37.04%
Dec 31, 2001	21.60M	-15.63%

View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	679.94B
UnitedHealth Group	533.82B
Johnson & Johnson	370.25B
AbbVie	312.76B
Novo Nordisk	286.28B
Abbott Laboratories	218.91B
AstraZeneca	210.97B
Novartis AG	209.02B

Market Cap Rankings